Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of serotonin receptor modulators. Its structure supports the creation of bioactive molecules with potential applications in treating neurological and psychiatric disorders. The trifluoromethyl group enhances metabolic stability and binding affinity, making it valuable in medicinal chemistry for optimizing drug candidates. Also employed in research settings to design novel compounds with improved pharmacokinetic properties.